Maximal exercise, limb ischemia, and endothelial progenitor cells
Authors:
- 1 May 2010
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 18 (1) , 55-64
Abstract
The concept of neovascularization in response to tissue ischemia was recently extended by the finding of postnatal vasculogenesis through circulating endothelial progenitor cells (EPCs). The aim of this study was to assess the role of acute ischemia for EPC mobilization in patients with peripheral arterial occlusive disease (PAOD) and in healthy volunteers. The number of circulating EPCs was analyzed by flow cytometry in PAOD patients (n = 23) with exercise-induced limb ischemia for up to 72 h after a maximal treadmill test and in healthy volunteers (n = 17) who underwent a 15-min suprasystolic occlusion of one lower extremity to induce limb ischemia. Plasma concentrations of vascular endothelial growth factor, basic fibroblast growth factor, tumor necrosis factor-α, and granulocyte macrophage-colony stimulating factor were determined by ELISA. EPCs (CD 34 pos/KDRpos) increased significantly in both PAOD patients from 82 ± 20 to 256 ± 52 (P < 0.05) and healthy volunteers from 144 ± 39 to 590 ± 61 cells per 1 million events (P < 0.05) in response to induced ischemia, with a maximum after 24 h and returned to baseline within 72 h. The relative increase in EPC numbers was significantly lower in patients with PAOD as compared with healthy volunteers (P < 0.05). Plasma levels of vascular endothelial growth factor increased from 27.4 ± 3.1 to 126.4 ± 12 pg/ml in patients with PAOD (P < 0.05) and from 30.7 ± 6.1 to 134.1 ± 12.4 pg/ml in healthy volunteers (P < 0.05). Both patients with symptomatic PAOD and healthy volunteers respond to a single episode of limb ischemia with a time-dependent increase in circulating EPCs. The increase of EPC numbers in response to ischemia is reduced when vascular disease is present, underlining the reduced vasculogenic potential of patients with PAOD.Keywords
This publication has 32 references indexed in Scilit:
- Autologous Bone-Marrow Mononuclear Cell Implantation Improves Endothelium-Dependent Vasodilation in Patients With Limb IschemiaCirculation, 2004
- Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial IschemiaCirculation, 2003
- LDL‐apheresis up‐regulates VEGF and IGF‐I in patients with ischemic limbJournal of Clinical Apheresis, 2003
- Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trialThe Lancet, 2002
- Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial InfarctionCirculation, 2001
- Endothelial Cells of Hematopoietic Origin Make a Significant Contribution to Adult Blood Vessel FormationCirculation Research, 2000
- Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences of the United States of America, 2000
- Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological NeovascularizationCirculation Research, 1999
- VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cellsThe EMBO Journal, 1999
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999